U.S. Opioids Market, By Drug Type (Oxycodone, Hydrocodone, Morphine, Codeine, Methadone, and Others), By Therapeutic Application (Pain Management, Cough Treatment, and Diarrhea Treatment), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

Published In : May 2024

Code : CMI1048

Pages :156

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Concentration and Competitive Landscape

US Opioids Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing Product Launches by Key Market Players

Increasing adoption of organic growth strategies, such as product launches by key market players, are expected to drive the market growth over the forecast period. For instance, in July 2022, Protega Pharmaceuticals LLC, a specialty pharmaceutical company that aims to advance solutions in the field of prescription drug abuse deterrence, announced the commercial launch of RoxyBond (oxycodone) immediate-release (IR) tablets in the U.S.

Key Players Insights